A New Era of Targeting the Ancient Gatekeepers of the Immune System: Toll-Like Agonists in the Treatment of Allergic Rhinitis and Asthma

Publisher： Karger

E-ISSN： 1423-0097|164|1|46-63

ISSN： 1018-2438

Source： International Archives of Allergy and Immunology, Vol.164, Iss.1, 2014-05, pp. : 46-63

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Expression of Toll‐like receptors in nasal epithelium in allergic rhinitis

By  

APMIS (ELECTRONIC), Vol. 123, Iss. 8, 2015-08 ,pp. : 716-725

John Wiley & Sons Inc

Access to resources Recommend Favorite

Montelukast in the treatment of asthma and allergic rhinitis

By Neighbour Helen   McIvor Andrew  

Clinical Practice, Vol. 10, Iss. 3, 2013-05 ,pp. : 257-263

Future Medicine

Access to resources Recommend Favorite

Comparative Effects of Desloratadine versus Montelukast on Asthma Symptoms and Use of β2-Agonists in Patients with Seasonal Allergic Rhinitis and Asthma

By  

International Archives of Allergy and Immunology, Vol. 130, Iss. 4, 2003-05 ,pp. : 307-313

Karger

Access to resources Recommend Favorite

Improvement and prevention of asthma with concomitant treatment of allergic rhinitis and allergen‐specific therapy

By  

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, Vol. 5, Iss. S1, 2015-09 ,pp. : S45-S50

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment and Outcomes in Patients with Asthma and Allergic Rhinitis in the United Kingdom

By  

International Archives of Allergy and Immunology, Vol. 142, Iss. 4, 2006-11 ,pp. : 318-328

Karger

Access to resources Recommend Favorite